The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106763367 10676336 7 F 20160909 20141226 20160919 EXP US-ALEXION PHARMACEUTICALS INC-A201404820 ALEXION 0.00 M Y 0.00000 20160919 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106763367 10676336 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, UNK U T3-AD3745B01 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION
106763367 10676336 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, UNK U 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106763367 10676336 1 Paroxysmal nocturnal haemoglobinuria

Outcome of event

Event ID CASEID OUTC COD
106763367 10676336 HO
106763367 10676336 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
106763367 10676336 Appendicitis
106763367 10676336 Asthenia
106763367 10676336 Chest pain
106763367 10676336 Condition aggravated
106763367 10676336 Cyst
106763367 10676336 Dizziness
106763367 10676336 Drug hypersensitivity
106763367 10676336 Fatigue
106763367 10676336 Lethargy
106763367 10676336 Neutrophil count decreased
106763367 10676336 Pyrexia
106763367 10676336 Rash
106763367 10676336 Red blood cell count decreased
106763367 10676336 Throat tightness
106763367 10676336 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106763367 10676336 2 20141209 0